Therapeutics Development Initiative 2010
Industry-exclusive funding for preclinical PD research
09/15/2009
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) announces the launch of the Therapeutics Development Initiative – Spring 2010, a funding mechanism to support and stimulate preclinical Parkinson’s disease research at for-profit institutions. Part of the annual Pipeline Programs, this funding program seeks to support preclinical development of Parkinson’s disease therapies which have the potential for fundamentally altering disease course and/or improving treatment of symptoms above and beyond current standards of care. Proposals must focus on key and critical preclinical studies necessary for developing, optimizing and evaluating therapeutic strategies that, if successful, can move into human testing.
Responsibility for the planning, direction, and execution of the proposed project will be solely that of the principal investigator who must be an employee of a for-profit entity. Academic investigators may have an advisory role in the project, but the operational and strategic ownership of the project must reside within the company.
Please note that pre-proposals are mandatory for the Therapeutics Development Initiative – Spring 2010 program and will be used to evaluate your proposal’s fit with the stated aims and review criteria of the RFP. All pre-proposals received in response to this program will be subjected to a triage process and only those pre-proposals deemed to be of suitable scientific merit will be invited to submit a full application.
Further program details, guidance about the types of proposals and focus areas of greatest interest to MJFF, and instructions for submission can be found in the RFP.
Note: The TDI program is launched approximately every six months. If you are unable to submit to the Spring 2010 funding cycle, the deadline for submission to the next cycle will be in June 2010.
MJFF employs an expedited, abbreviated granting mechanism to accelerate discoveries and ultimately translate findings to PD patients more quickly.
Submission Deadlines:
6 p.m. ET, Tuesday, December 15, 2009 (Spring Cycle)
6 p.m. ET, Tuesday, June 1, 2010 (Fall Cycle)
Anticipated Funding:
June 2010 (Spring Cycle)
December 2010 (Fall Cycle)
Please click on the links below for all submission information:
Conference Call
MJFF will hold a 45 minute long conference call on October 22, 2009 at 12:00 PM U.S. Eastern Time to clarify and explain the Therapeutics Development Initiative 2010 program and to answer applicants' questions. To participate in this call, you must RSVP via email to conferencecalls@michaeljfox.org. Participants will receive a reply with call-in details.
Application process information
Press Release
To view this press release, click here.
Therapeutics Development Initiative 2010 -- RFP
To view the file, click here.
Therapeutics Development Initiative 2010 -- Pre-Proposal Instructions
To view the file, click here.
Therapeutics Development Initiative 2010 -- Therapeutic Summary Template
To view the file, click here.
To begin an application for this program online: click here.
For additional information about this initiative, contact the Foundation at research@michaeljfox.org.
